Galapagos NV (GLPG)

53.08
-0.26(-0.49%)
  • Volume:
    210,555
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    52.98 - 54.08

GLPG Overview

Prev. Close
53.34
Day's Range
52.98-54.08
Revenue
558.46M
Open
53.54
52 wk Range
41.3-66.86
EPS
-1.59
Volume
210,555
Market Cap
3.48B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
279,368
P/E Ratio
-
Beta
0.48
1-Year Change
-12.18%
Shares Outstanding
65,648,221
Next Earnings Date
03 Aug 2022
What is your sentiment on Galapagos?
or
Market is currently closed. Voting is open during market hours.

Galapagos NV News

  • Galapagos ADR Earnings, Revenue beat in Q1
    • ByInvesting.com-

    Investing.com - Galapagos ADR reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations. Galapagos ADR announced earnings per...

  • Galapagos ADR Earnings, Revenue beat in Q4
    • ByInvesting.com-

    Investing.com - Galapagos ADR reported on Thursday fourth quarter earnings that beat analysts' forecasts and revenue that topped expectations. Galapagos ADR announced earnings...

Galapagos NV Company Profile

Galapagos NV Company Profile

Employees
1319

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company aims to develop a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. In addition, the Company’s mission is to develop a number of medicines based on the discovery of novel targets. Galapagos NV also discovers which proteins that are involved in causing diseases such as, rheumatoid, arthritis, inflammatory bowel disease and fibrosis. Galapagos aims to develop small molecules that inhibit these targets, restore the balance and thereby positively influence the course of the disease.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • 💩
    0
    • time to replace mgmt by some more competent people? looks like they lost it and can not get a grip anymore????what failure is next in the pipeline?!
      0